Skip to main content
Jonathan Powell, MD, Oncology, Baltimore, MD

JonathanDavidPowellMD

Oncology Baltimore, MD

Associate Professor, Oncology, Johns Hopkins University School of Medicine

Are you Dr. Powell?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 77 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-8964

Summary

  • Dr. Jonathan Powell, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Massachusetts. He is an Associate Professor at Johns Hopkins University School of Medicine.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1992

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1996 - 2025
  • MA State Medical License
    MA State Medical License 1995 - 2000

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2010

Publications & Presentations

PubMed

Press Mentions

  • GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with Lilly
    GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with LillyMarch 31st, 2020
  • Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from Deerfield
    Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from DeerfieldMarch 22nd, 2018
  • Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-Oncology
    Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-OncologyMarch 9th, 2017
  • Join now to see all